Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Haseena Sahib"'
Autor:
Imran Chaudhri, Richard Moffitt, Erin Taub, Raji R. Annadi, Minh Hoai, Olena Bolotova, Jeanwoo Yoo, Simrat Dhaliwal, Haseena Sahib, Farah Daccueil, Janos Hajagos, Mary Saltz, Joel Saltz, Sandeep K. Mallipattu, Farrukh M. Koraishy
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-15 (2020)
Introduction: Acute kidney injury (AKI) is strongly associated with poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19), but data on the association of proteinuria and hematuria are limited to non-US populations. In additi
Externí odkaz:
https://doaj.org/article/7405d3d77aa44f559b89d6046f9b31b7
Autor:
Olena Bolotova, Jeanwoo Yoo, Imran Chaudhri, Luis A Marcos, Haseena Sahib, Farrukh M Koraishy, Hal Skopicki, Sahar Ahmad, Sandeep K Mallipattu
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244708 (2020)
BackgroundRetrospective studies on the use of Renin-Angiotensin-Aldosterone System blockade in patients with Coronavirus Disease 2019 (COVID-19) have been informative but conflicting, and prospective studies are required to demonstrate the safety, to
Externí odkaz:
https://doaj.org/article/66f4daf219994b2b81a7b97a9f6ca24c
Publikováno v:
Blood Purification
Introduction: Mechanism(s) mediating critical illness in coronavirus disease 2019 (COVID-19) remain unclear. Previous reports demonstrate the existence of endotoxemia in viral infections without superimposed gram-negative bacteremia, but the rate and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2607e7cc7f7a3ea9ef77aefa9e02f27
https://doi.org/10.1159/000518230
https://doi.org/10.1159/000518230
Autor:
Joel H. Saltz, Simrat Dhaliwal, I. Chaudhri, Mary M. Saltz, Sandeep K. Mallipattu, Jeanwoo Yoo, Minh Hoai, Richard A. Moffitt, Farah Daccueil, Farrukh M. Koraishy, Raji R. Annadi, O. Bolotova, Janos Hajagos, Erin Taub, Haseena Sahib
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-15 (2020)
Introduction: Acute kidney injury (AKI) is strongly associated with poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19), but data on the association of proteinuria and hematuria are limited to non-US populations. In additi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7d5b0732553c7c562c6b2cf4add184
https://www.karger.com/Article/FullText/511946
https://www.karger.com/Article/FullText/511946
Autor:
Sandeep K. Mallipattu, Haseena Sahib, Luis A. Marcos, Farrukh M. Koraishy, O. Bolotova, Sahar Ahmad, Jeanwoo Yoo, I. Chaudhri, Hal Skopicki
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0244708 (2020)
PLOS ONE, 15(12):e0244708
PLoS ONE, Vol 15, Iss 12, p e0244708 (2020)
PLOS ONE, 15(12):e0244708
Background Retrospective studies on the use of Renin-Angiotensin-Aldosterone System blockade in patients with Coronavirus Disease 2019 (COVID-19) have been informative but conflicting, and prospective studies are required to demonstrate the safety, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80876e9941af7fff630d3192ca64bcb5
https://pubmed.ncbi.nlm.nih.gov/33378401
https://pubmed.ncbi.nlm.nih.gov/33378401